EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

The Endocrine Disrupting Compounds Bisphenol‐A and α‐Zeranol Mimic the Estrogen Transcriptional Program to Promote Proliferation and Stemness in Breast Cancer Cells

Cassandra Winz iD, Eric Li, Caroline Xie, Kyo Chang Lee, Kevin Boguszewski, Shlok Rohatagi, Rita Hahn, Ray Rancourt, Philip Furmanski, Nanjoo Suh iD

Molecular Carcinogenesis · 2026

DOI: 10.1002/mc.70127 ↗

At a glance

Journal article in Molecular Carcinogenesis, 2026. Written by Cassandra Winz and 9 co-authors. Institution: Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA. Major MEDLINE topics: Benzhydryl Compounds, Phenols, Neoplastic Stem Cells, Cell Proliferation. Cited 2 times so far (Crossref); 43 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIEHS NIH HHS, NIH HHS, NCI NIH HHS.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Excessive activation of the estrogen receptor (ER) drives proliferation, progression, and the formation of breast cancer stem cells (CSCs) in ER‐positive breast cancer. Estrogenic endocrine disrupting compounds (EDCs) found in plastics, water, and food are also able to bind to the ER. Thus, we hypothesized that estrogenic EDCs mimic estrogen (E2) in the pathogenesis of breast cancer by promoting their survival and proliferation. Three estrogenic EDCs routinely found in human biosamples were selected for analysis: bisphenol‐A (BPA), diethyl‐hexyl phthalate (DEHP), and alpha‐zeranol (αZAL). We assessed proliferation, transcriptional reprogramming, and CSC formation in breast cancer cell lines. E2, BPA, and αZAL significantly increased cell proliferation in ER‐positive, but not ER‐negative cell lines. This was reversed after administration of the ER‐antagonist, ICI 182,780. BPA and αZAL upregulated estrogen target genes (PGR, TFF1) and increased levels of cell‐cycle protein. RNA sequencing analysis revealed that BPA and αZAL altered expression of genes related to cell division, DNA repair, and estrogen signaling, with a substantial transcriptional overlap between EDCs and estrogen treatments. Additionally, BPA and αZAL increased the proportion of CSCs, defined as the CD24 low /CD44 high expressing subpopulation. Overall, these data indicate that BPA and αZAL act as functional estrogen mimics in breast cancer cells, activating canonical estrogen signaling pathways and promoting stem‐like characteristics. Notably, this study provides the first transcriptomic and stem‐associated characterization of αZAL in ER‐positive breast cancer cells, revealing a robust estrogenic mode of action. This work provides mechanistic insight into how environmental EDCs may influence ER‐positive breast cancer biology.

Subjects

MeSH terms (MEDLINE)

Benzhydryl CompoundsPhenolsNeoplastic Stem CellsCell ProliferationBreast NeoplasmsEndocrine DisruptorsEstrogensHumansBisphenol A CompoundsFemaleGene Expression Regulation, NeoplasticCell Line, TumorTranscription, GeneticDiethylhexyl PhthalateReceptors, Estrogen

Author keywords

breast cancercancer stem cellsendocrine disrupting compoundsestrogen

Substances

Benzhydryl CompoundsBisphenol A CompoundsPhenolsbisphenol AEndocrine DisruptorsEstrogensDiethylhexyl PhthalateReceptors, Estrogen

Authors and institutions

  • Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.
  • Joint Graduate Program in Toxicology at Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.
  • Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.
  • Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.

ORCID profiles: Cassandra Winz, Nanjoo Suh

Funding

  • NIEHS NIH HHS
  • NIH HHS
  • NCI NIH HHS
  • Charles and Johanna Busch Memorial Fund at Rutgers University
  • NCCIH NIH HHS
  • Trustees Research Fellowship Program at Rutgers University
  • National Institutes of Health

Cite

APA

Winz, C., Li, E., Xie, C., Lee, K. C., Boguszewski, K., Rohatagi, S., Hahn, R., Rancourt, R., Furmanski, P., & Suh, N. (2026). The Endocrine Disrupting Compounds Bisphenol‐A and α‐Zeranol Mimic the Estrogen Transcriptional Program to Promote Proliferation and Stemness in Breast Cancer Cells. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70127

Vancouver

Winz C, Li E, Xie C, Lee KC, Boguszewski K, Rohatagi S, et al. The Endocrine Disrupting Compounds Bisphenol‐A and α‐Zeranol Mimic the Estrogen Transcriptional Program to Promote Proliferation and Stemness in Breast Cancer Cells. Molecular Carcinogenesis. 2026. doi:10.1002/mc.70127

BibTeX
@article{Winz2026,
  author = {Winz, Cassandra and Li, Eric and Xie, Caroline and Lee, Kyo Chang and Boguszewski, Kevin and Rohatagi, Shlok and Hahn, Rita and Rancourt, Ray and Furmanski, Philip and Suh, Nanjoo},
  title = {The Endocrine Disrupting Compounds Bisphenol‐A and α‐Zeranol Mimic the Estrogen Transcriptional Program to Promote Proliferation and Stemness in Breast Cancer Cells},
  journal = {Molecular Carcinogenesis},
  year = {2026},
  doi = {10.1002/mc.70127}
}
Start for free →